Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Jul 21, 2016, 13:00 ET Mylan Publishes Supplement to Meda Offer Document

 The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares...


Jul 21, 2016, 13:00 ET Mylan offentliggör tillägg till erbjudandehandlingen avseende Meda

Erbjudandet lämnas inte, och detta pressmeddelande får inte distribueras, vare sig direkt eller indirekt, i eller till, och inga...


Jul 21, 2016, 13:00 ET Advil convida população para mutirão de acessibilidade em 28 de julho

Trabalhar, passear, fazer compras ou estudar. A rotina está repleta de atividades que não podemos deixar de cumprir. Só percebemos a...


Jul 21, 2016, 12:47 ET Alamo Pharma Services COO Shares Keys to Successful Pharmaceutical Product Launches at Second Annual Life Sciences Summit

 On June 29, 2016, Peter Marchesini, Chief Operating Officer of Alamo Pharma Services®, participated in CBI's Second Annual Life Sciences...


Jul 21, 2016, 10:30 ET Antibodies Market: North America's Revenue Share to Reach 44% in 2016

High rate of product approvals, combined with rising adoption of therapeutic antibodies in developing economies is positively influencing the...


Jul 21, 2016, 10:00 ET Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency

Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced today that the European Medicines Agency (EMA) has...


Jul 21, 2016, 09:21 ET Se amplía el programa de acceso mundial VIH de Roche

El programa de acceso mundial VIH de Roche se amplía para incluir soluciones de plataforma automatizada de próxima generación Los...


Jul 21, 2016, 09:01 ET Stem Cell Therapies Facing Commercial Challenges Despite Promising Pipeline, Says GBI Research

A new report from business intelligence provider GBI Research - Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D...


Jul 21, 2016, 09:00 ET Amgen And Allergan Announce Top-Line Results From Phase 3 Study Evaluating ABP 980 Compared With Trastuzumab In Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

 Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced results from a Phase 3 study evaluating efficacy and safety of ABP 980...


Jul 21, 2016, 08:30 ET DelMar Pharmaceuticals Announces Presentation at the European Association of Neuro-Oncology (EANO) Annual Meeting in October 2016

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on the development and...


Jul 21, 2016, 08:30 ET Sensus Healthcare, Inc. Announces Separation of Units Sold in IPO

 Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...


Jul 21, 2016, 08:30 ET LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical

LabStyle Innovations Corp. (NASDAQ:DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today that it has signed an...


Jul 21, 2016, 08:05 ET Aytu BioScience Announces Publication of Peer-Reviewed Study Demonstrating the Utility of MiOXSYS™ in the Assessment of Male Infertility

Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of...


Jul 21, 2016, 08:00 ET BioPharmX Study Shows BPX-01 Topical Gel Delivers Minocycline Precisely to the Skin

 BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, will share findings...


Jul 21, 2016, 08:00 ET Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 2016 (AAIC® 2016)

 Eli Lilly and Company (NYSE:LLY) today announced it will present findings from more than 25 research studies at the upcoming Alzheimer's...


Jul 21, 2016, 08:00 ET PTC Therapeutics to Host Conference Call to Discuss Second Quarter Financial Results

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter...


Jul 21, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 2016 Summer Meeting of the American Academy of Dermatology

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant...


Jul 21, 2016, 07:00 ET Shire Launches Pediatric Indication for Immunodeficiency Treatment HyQvia in Europe

HyQvia (Human Normal Immunoglobulin 10% and Recombinant Human Hyaluronidase) is the only subcutaneous IG treatment for primary and certain...


Jul 21, 2016, 07:00 ET LifeBond Receives FDA IDE Approval for LifeSeal GI Surgical Sealant Clinical Trial

LifeBond, a leader in the development of bio-surgical medical devices for tissue repair, announced today that it has received a U.S. Food and...


Jul 21, 2016, 06:00 ET United Therapeutics Corporation To Announce Second Quarter 2016 Financial Results Before The Market Opens On Thursday, July 28, 2016

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2016 financial results before the market...


Jul 21, 2016, 06:00 ET Egalet to Host Conference Call and Webcast on August 4, 2016 to Discuss Second Quarter 2016 Financial Results

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...


Jul 21, 2016, 04:00 ET Nuclear Medicine Market - 8.34% CAGR to 2020 Driven by Radiopharmaceuticals Demand

According to the 2016 nuclear medicine market report, the demand for radiopharmaceuticals is driving the market growth with most radioactive...


Jul 20, 2016, 20:55 ET Perrigo Announces Leadership Change in Rx Pharmaceuticals Segment

 Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE), a leading global provider of Quality Affordable Healthcare...


Jul 20, 2016, 17:00 ET Rhythm Announces New England Journal of Medicine Publication of Setmelanotide Phase 2 Data for Treatment of POMC Deficiency Obesity

Rhythm, a biopharmaceutical company developing peptide therapeutics for rare genetic deficiencies that result in life-threatening metabolic...


Jul 20, 2016, 15:51 ET GSK ships 2016-17 seasonal influenza vaccines for US market

 GSK [LSE/NYSE: GSK] announced today it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and...